TBPH

Theravance Biopharma, Inc.

SEC CIK 1583107
$16.49 −17.5% · 90 days
90-day buys
$0
0 open-market
90-day sells
$433.6K
3 open-market
Net insider flow
−$433.6K
Net selling
Filings shown
34
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at TBPH have sold a net $433.6K of stock (0 open-market buys vs 3 sells).

Largest recent trade: Broshy Eran sold $545.8K of TBPH, trimming their stake 32%.

Most active filer: Farnum Rhonda, with 10 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for TBPH, newest first
View on SEC EDGAR ↗
Advertisement
TBPH
Sell Farnum Rhonda · SVP, COMM & MEDICAL AFFAIRS · Open-market sale · filed Mar 18, 2026 ΔOwn −2.9%

Farnum Rhonda sold $108.1K of TBPH, trimming their stake 3%.

−$108.1K
7,767 sh @ $14
TBPH
Sell Farnum Rhonda · SVP, COMM & MEDICAL AFFAIRS · Open-market sale · filed Mar 18, 2026 ΔOwn −6.1%

Farnum Rhonda sold $217.5K of TBPH, trimming their stake 6%.

−$217.5K
15,534 sh @ $14
TBPH
Sell Farnum Rhonda · SVP, COMM & MEDICAL AFFAIRS · Open-market sale · filed Mar 18, 2026 ΔOwn −3.2%

Farnum Rhonda sold $108.1K of TBPH, trimming their stake 3%.

−$108.1K
7,766 sh @ $14
TBPH
Sell Farnum Rhonda · SVP, COMM & MEDICAL AFFAIRS · Open-market sale · filed Dec 5, 2025 ΔOwn −2.5%

Farnum Rhonda sold $145.6K of TBPH, trimming their stake 3%.

−$145.6K
7,767 sh @ $19
TBPH
Sell Farnum Rhonda · SVP, COMM & MEDICAL AFFAIRS · Open-market sale · filed Dec 5, 2025 ΔOwn −2.6%

Farnum Rhonda sold $145.6K of TBPH, trimming their stake 3%.

−$145.6K
7,766 sh @ $19
TBPH
Sell Farnum Rhonda · SVP, COMM & MEDICAL AFFAIRS · Open-market sale · filed Dec 5, 2025 ΔOwn −5.3%

Farnum Rhonda sold $291.3K of TBPH, trimming their stake 5%.

−$291.3K
15,534 sh @ $19
TBPH
Sell BROSHY ERAN · Director · Open-market sale · filed Dec 1, 2025 ΔOwn −19%

Broshy Eran sold $280K of TBPH, trimming their stake 19%.

−$280K
14,000 sh @ $20
TBPH
Sell BROSHY ERAN · Director · Open-market sale · filed Dec 1, 2025 ΔOwn −26%

Broshy Eran sold $310K of TBPH, trimming their stake 26%.

−$310K
15,501 sh @ $20
TBPH
Sell BROSHY ERAN · Director · Open-market sale · filed Nov 13, 2025 ΔOwn −32%

Broshy Eran sold $545.8K of TBPH, trimming their stake 32%.

−$545.8K
29,500 sh @ $19
Advertisement

About TBPH insider activity

This page tracks every recent Form 4 filed for Theravance Biopharma, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is TBPH insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Theravance Biopharma, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.